DÄ internationalArchive7/2020The palliative care of patients with incurable cancers

Clinical Practice Guideline

The palliative care of patients with incurable cancers

Dtsch Arztebl Int 2020; 117: 108-15. DOI: 10.3238/arztebl.2020.0108

Simon, S T; Pralong, A; Radbruch, L; Bausewein, C; Voltz, R

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Die Schreibweise im Original lautet: „nicht-heilbare Krebserkrankung“.
Im vorliegenden Text wird einheitlich die zusammengesetzte Form (nichtheilbar)
nach Pschychrembel verwendet.
*1 Die beiden Autoren teilen sich gleichberechtigt die Erstautorenschaft.
*2 Die beiden Autoren teilen sich gleichberechtigt die Letztautorenschaft.
Zentrum für Palliativmedizin, Uniklinik Köln: PD Dr. med. Steffen T. Simon,
Dr. med. Anne Pralong, Prof. Dr. med. Raymond Voltz
Centrum Integrierte Onkologie Aachen, Bonn, Köln, Düsseldorf (CIO ABCD):
PD Dr. med. Steffen T. Simon, Dr. med. Anne Pralong, Prof. Dr. med. Lukas Radbruch,
Prof. Dr. med. Raymond Voltz
Klinik für Palliativmedizin, Universitätsklinikum Bonn: Prof. Dr. med. Lukas Radbruch
Klinik und Poliklinik für Palliativmedizin, LMU München, Klinikum der Universität München:
Prof. Dr. med. Claudia Bausewein
1.Bausewein C, Simon ST, Pralong A, Radbruch L, Nauck F, Voltz R: Clinical practice guideline: palliative care of adult patients with cancer. Dtsch Arztebl Int 2015; 112: 863–70 VOLLTEXT
2.Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Palliativmedizin für Patienten mit einer nicht-heilbaren Krebserkrankung, Langversion 2.0, 2019, AWMF-Registernummer: 128/001OL, www.leitlinienprogramm-onkologie.de/leitlinien/palliativmedizin/ (last accessed on 7 October 2019).
3.Dittus KL, Gramling RE, Ades PA: Exercise interventions for individuals with advanced cancer: a systematic review. Prev Med 2017; 104: 124–32 CrossRef MEDLINE
4.Adamsen L, Quist M, Andersen C, et al.: Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ 2009; 339: b3410 CrossRef MEDLINE PubMed Central
5.Poort H, Peters M, Bleijenberg G, et al.: Psychosocial interventions for fatigue during cancer treatment with palliative intent. Cochrane Database Syst Rev 2017; 7: CD012030 CrossRef MEDLINE PubMed Central
6.Mücke M, Mochamat, Cuhls H, et al.: Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 2015; 5: CD006788 CrossRef MEDLINE PubMed Central
7.Sela RA, Watanabe S, Nekolaichuk CL: Sleep disturbances in palliative cancer patients attending a pain and symptom control clinic. Palliat Support Care 2005; 3: 23–31 CrossRef MEDLINE
8.Riemann D, Baum E, Cohrs S, et al.: S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Kapitel „Insomnie bei Erwachsenen“ (AWMFRegisternummer 063–003), Update 2016. Somnologie 2017; 21: 2–44 CrossRef
9.Joffe H, Partridge A, Giobbie-Hurder A, et al.: Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. Menopause 2010; 17: 908–16 CrossRef MEDLINE
10.Cankurtaran ES, Ozalp E, Soygur H, Akbiyik DI, Turhan L, Alkis N: Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine. Support Care Cancer 2008; 16: 1291–8 CrossRef MEDLINE
11.Palesh OG, Mustian KM, Peppone LJ, et al.: Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Sleep Med 2012; 13: 1184–90 CrossRef MEDLINE PubMed Central
12.Pasquini M, Speca A, Biondi M: Quetiapine for tamoxifen-induced insomnia in women with breast cancer. Psychosomatics 2009; 50: 159–61 CrossRef MEDLINE
13.Kurdi MS, Muthukalai SP: The efficacy of oral melatonin in improving sleep in cancer patients with insomnia: a randomized double-blind placebo-controlled study. Indian J 2016; 22: 295–300 CrossRef MEDLINE PubMed Central
14.Laugsand EA, Kaasa S, Klepstad P: Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations. Palliat Med 2011; 25: 442–53 CrossRef MEDLINE
15.Sande TA, Laird BJA, Fallon MT: The management of opioid-induced nausea and vomiting in patients with cancer: a systematic review. J Palliat Med 2018; 21: 21.
16.Benze G, Alt-Epping B, Geyer A, Nauck F: [Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review]. Schmerz 2012a; 26: 500–14 CrossRef MEDLINE
17.Caraceni A, Hanks G, Kaasa S, et al.: Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012; 13: e58–68 CrossRef
18.Dietz I, Schmitz A, Lampey I, Schulz C: Evidence for the use of levomepromazine for symptom control in the palliative care setting: a systematic review. BMC Palliat Care 2013; 12: 2 CrossRef MEDLINE PubMed Central
19.Benze G, Geyer A, Alt-Epping B, Nauck F: [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients: a systematic review]. Schmerz 2012; 26: 481–99 CrossRef MEDLINE
20.Vayne-Bossert P, Haywood A, Good P, Khan S, Rickett K, Hardy JR: Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery). Cochrane Database Syst Rev 2017; 7: CD012002 CrossRef MEDLINE PubMed Central
21.Naghibi M, Smith TR, Elia M: A systematic review with meta-analysis of survival, quality of life and cost-effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clin Nutr 2015; 34: 825–37 CrossRef MEDLINE
22.Sowerbutts AM, Lal S, Sremanakova J, et al.: Home parenteral nutrition for people with inoperable malignant bowel obstruction. Cochrane Database Syst Rev 2018; 8: CD012812 CrossRef MEDLINE PubMed Central
23.Arends J, Bachmann P, Baracos V, et al.: ESPEN guidelines on nutrition in cancer patients. Clin Nutr 2017; 36: 11–48 CrossRef MEDLINE
24.Feuer DJ, Broadley KE: Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev 2000: CD001219 CrossRef PubMed Central
25.Kaneishi K, Kawabata M, Morita T: Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction. J Pain Symptom Manage 2012; 44: 604–7 CrossRef MEDLINE
26.Obita GP, Boland EG, Currow DC, Johnson MJ, Boland JW: Somatostatin analogues compared with placebo and other pharmacologic agents in the management of symptoms of inoperable malignant bowel obstruction: a systematic review. J Pain Symptom Manage 2016; 52: 901–19.e1 CrossRef MEDLINE
27.LeBon B, Zeppetella G, Higginson IJ: Effectiveness of topical administration of opioids in palliative care: a systematic review. J Pain Symptom Manage 2009; 37: 913–7 CrossRef MEDLINE
28.Norman G, Dumville JC, Moore ZE, Tanner J, Christie J, Goto S: Antibiotics and antiseptics for pressure ulcers. Cochrane Database Syst Rev 2016; 4: CD011586 CrossRef PubMed Central
29.da Costa Santos CM, de Mattos Pimenta CA, Nobre MR: A systematic review of topical treatments to control the odor of malignant fungating wounds. J Pain Symptom Manage 2010; 39: 1065–76 CrossRef MEDLINE
30.Ramasubbu DA, Smith V, Hayden F, Cronin P: Systemic antibiotics for treating malignant wounds. Cochrane Database Syst Rev 2017; 8: CD011609 CrossRef MEDLINE PubMed Central
31.Montroy J, Hutton B, Moodley P, et al.: The efficacy and safety of topical tranexamic acid: a systematic review and meta-analysis. Transfus Med Rev 2018; pii: S0887–7963(17)30151–7].
32.Fulton JJ, Newins AR, Porter LS, Ramos K: Psychotherapy targeting depression and anxiety for use in palliative care: a meta-analysis. J Palliat Med 2018; 21: 1024–37 CrossRef MEDLINE
33.Nubling G, Allmendinger S, Lorenzl S: [Drug therapy of anxiety and fear in palliative care patients with cancer or other illnesses: a systematic review]. Schmerz 2012; 26: 537–49 CrossRef MEDLINE
34.Stockler MR, O‘Connell R, Nowak AK, et al.: Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol 2007; 8: 603–12 CrossRef
35.Rodriguez-Prat A, Balaguer A, Booth A, Monforte-Royo C: Understanding patients‘ experiences of the wish to hasten death: an updated and expanded systematic review and meta-ethnography. BMJ Open 2017; 7: e016659 CrossRef MEDLINE PubMed Central
36.Blades CA, Stritzke WGK, Page AC, Brown JD: The benefits and risks of asking research participants about suicide: a meta-analysis of the impact of exposure to suicide-related content. Clin Psychol Rev 2018; 64: 1–12 CrossRef MEDLINE
37.Temel JS, Greer JA, Muzikansky A, et al.: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733–42 CrossRef MEDLINE
38.Haun MW, Estel S, Rucker G, et al.: Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev 2017; 6: CD011129 CrossRef MEDLINE PubMed Central
39.Haywood A, Duc J, Good P, et al.: Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults. Cochrane Database Syst Rev 2019; 2: CD012704 CrossRef MEDLINE
40.Agar MR, Lawlor PG, Quinn S, et al.: Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med 2017; 177: 34–42 CrossRef MEDLINE
e1.Bandelow B, Lichte T, Rudolf S, Wiltink J, Beutel M: Clinical practice guideline: The diagnosis of and treatment recommendations for anxiety disorders. Dtsch Arztebl Int 2014; 111: 473–80 VOLLTEXT
e2.Ohnsorge K, Gudat H, Rehmann-Sutter C: Intentions in wishes to die: analysis and a typology—a report of 30 qualitative case studies of terminally ill cancer patients in palliative care. Psychooncology 2014; 23: 1021–6 CrossRef MEDLINE PubMed Central
e3.Ohnsorge K, Gudat H, Rehmann-Sutter C: What a wish to die can mean: reasons, meanings and functions of wishes to die, reported from 30 qualitative case studies of terminally ill cancer patients in palliative care. BMC Palliative Care 2014; 13: 38 CrossRef MEDLINE PubMed Central
e4.Nissim R, Gagliese L, Rodin G: The desire for hastened death in individuals with advanced cancer: a longitudinal qualitative study. Soc Sci Med 2009; 69: 165–71 CrossRef MEDLINE
e5.Balaguer A, Monforte-Royo C, Porta-Sales J, et al.: An international consensus definition of the wish to hasten death and its related factors. PLoS One 2016; 11: e0146184 CrossRef MEDLINE PubMed Central
e6.Lindner R: Suizidale Männer in der psychoanalytisch orientierten Psychotherapie. Eine systematische qualitative Untersuchung. Gießen: Psychosozial-Verlag; 2006.
e7.Wolfersdorf M, Etzersdorfer E: Suizid und Suizidprävention. 1st edition. Stuttgart: Kohlhammer 2011.
e8.Bausewein C, Roller S, Voltz R: Leitfaden Palliative Care. 5th ed. München: Urban & Fischer; 2015.
e9.British Columbia Cancer Agency: Symptom Management Guidelines: Care of malignant wounds. www.bccancer.bc.ca/nursing-site/Documents/Bibliograpy%20-%20Master%20List.pdf (last accessed on 24 January 2020).
e10.Deutsches Netzwerk für Qualitätsentwicklung in der Pflege: Expertenstandard – Pflege von Menschen mit chronischen Wunden. www.dnqp.de/fileadmin/HSOS/Homepages/DNQP/Dateien/Expertenstandards/Pflege_von_Menschen_mit_chronischen_Wunden/ChronWu_Akt_Auszug.pdf (last accessed on 24 January 2020).
e11.Onkologiepflege Schweiz: Pflege und Behandlung der malignen Wunde – Konzept/Leitfaden 2007.
e12.Seaman S: Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs 2006; 22: 185–93 CrossRef MEDLINE
e13.Uebach B: Wundversorgung in der Palliative Care (Teil 2). Zeitschrift für Palliativmedizin 2012; 13: 280–3 CrossRef
e14.Uebach B, Kern M: Wunden sind nicht immer heilbar – Palliative Wundbehandlung exulzerierender Tumorwunden. Bonn: PalliaMed Verlag; 2010.
e15.World Union of Wound Healing Societies (WUWHS): Principles of best practice: Wound exudate and the role of dressings. A consensus document. www.woundsinternational.com/media/issues/82/files/content_42.pdf (last accessed on 24 January 2020).